WallStreetZenWallStreetZen

NASDAQ: SNTI
Senti Biosciences Inc Stock Ownership - Who owns Senti Biosciences?

Insider buying vs selling

Have Senti Biosciences Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SNTI insiders and whales buy or sell their stock.

SNTI Shareholders

What type of owners hold Senti Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Omid Farokhzad19.95%9,128,403$2.83MInsider
Bayer Healthcare LLC12.85%5,878,488$1.82MInsider
New Enterprise Associates 15 LP9.67%4,426,151$1.37MInsider
Nea Management Company LLC9.67%4,426,151$1.37MInstitution
8vc GP I LLC5.55%2,537,558$786.64kInstitution
Ark Investment Management LLC4.31%1,969,860$610.66kInstitution
Timothy K. Lu4.20%1,922,276$595.91kInsider
Philip J. Lee2.05%936,424$290.29kInsider
Mostafa Ronaghi1.56%715,500$221.81kInsider
Vanguard Group Inc1.55%707,052$219.19kInstitution

1 of 3

SNTI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNTI25.05%52.51%
NERV6.78%93.22%Net Selling
VBIV3.92%96.08%Net Buying
NRBO0.25%99.75%
EVAX1.18%0.00%

Senti Biosciences Stock Ownership FAQ

Who owns Senti Biosciences?

Senti Biosciences (NASDAQ: SNTI) is owned by 25.05% institutional shareholders, 52.51% Senti Biosciences insiders, and 22.44% retail investors. Omid Farokhzad is the largest individual Senti Biosciences shareholder, owning 9.13M shares representing 19.95% of the company. Omid Farokhzad's Senti Biosciences shares are currently valued at $3.29M.

If you're new to stock investing, here's how to buy Senti Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.